The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis
Open accessAbstract
The triggering receptor expressed on myeloid cells (TREM)-1 is a recently discovered receptor expressed on the surface of neutrophils and a subset of monocytes. Engagement of TREM-1 has been reported to trigger the synthesis of proinflammatory cytokines in the presence of microbial products. Previously, we have identified a soluble form of TREM-1 (sTREM-1) and observed significant levels in serum samples from septic shock patients but not controls. Here, we investigated its putative role in the modulation of inflammation during sepsis. We observed that sTREM-1 was secreted by monocytes activated in vitro by LPS and in the serum of animals involved in an experimental model of septic shock. Both in vitro and in vivo, a synthetic peptide mimicking a short highly conserved domain of sTREM-1 appeared to attenuate cytokine production by human monocytes and protect septic animals from hyper-responsiveness and death. This peptide seemed to be efficient not only in preventing but also in down-modulating the deleterious effects of proinflammatory cytokines. These data suggest that in vivo modulation of TREM-1 by sTREM peptide might be a suitable therapeutic tool for the treatment of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Medzhitov, R., & Janeway, C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430506 · Cited by 1,825
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., & Lowry, S. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4845 · Cited by 845
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Induction of Direct Antimicrobial Activity Through Mammalian Toll-Like Receptors
Thoma-Uszynski, S., Stenger, S., Takeuchi, O., Ochoa, M. T., Engele, M., Sieling, P. A., Barnes, P. F., Röllinghoff, M., Bölcskei, P. L., Wagner, M., et al. (2001) · Science · doi:10.1126/science.291.5508.1544 · Cited by 729
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia
Gibot, S., Cravoisy, A., Levy, B., Bene, M.-C., Faure, G., & Bollaert, P.-E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031544 · Cited by 645
Self-citationHiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., & Bensi, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6231 · Cited by 585
Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock
Dinarello, C. A. (1997) · Chest · doi:10.1378/chest.112.6_supplement.321s · Cited by 508
Echtenacher, B., Falk, W., Männel, D. N., & Krammer, P. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3762 · Cited by 433
Gibot, S., Kolopp-Sarda, M.-N., Béné, M. C., Cravoisy, A., Levy, B., Faure, G. C., & Bollaert, P.-E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-1-200407060-00009 · Cited by 407
Self-citationBleharski, J. R., Kiessler, V., Buonsanti, C., Sieling, P. A., Stenger, S., Colonna, M., & Modlin, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3812 · Cited by 345
Eskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., & Remick, D. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2724 · Cited by 323
NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.
Urban, M. B., Schreck, R., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07707.x · Cited by 287
Colonna, M., & Facchetti, F. (2003) · The Journal of Infectious Diseases · doi:10.1086/374754 · Cited by 281
Collart, M. A., Baeuerle, P., & Vassalli, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1498-1506.1990 · Cited by 235
Clinical Trials of Immunomodulatory Therapies in Severe Sepsis and Septic Shock
Vincent, J., Sun, Q., & Dubois, M. (2002) · Clinical Infectious Diseases · doi:10.1086/339549 · Cited by 228
Lantz, M., Gullberg, U., Nilsson, E., & Olsson, I. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114853 · Cited by 221
TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development
Gingras, M., Lapillonne, H., & Margolin, J. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00004-4 · Cited by 141
Search for Sepsis Drugs Goes on Despite Past Failures
Stone, R. (1994) · Science · doi:10.1126/science.8153620 · Cited by 130
Strategies for the Treatment of Sepsis
Warren, H. S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361311 · Cited by 117
TREM-1: A new regulator of innate immunity in sepsis syndrome
Nathan, C., & Ding, A. H. (2001) · Nature Medicine · doi:10.1038/87846 · Cited by 100
Echtenacher, B., Weigl, K., Lehn, N., & Männel, D. N. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3550-3555.2001 · Cited by 96
Crystal Structure of the Human Myeloid Cell Activating Receptor TREM-1
Radaev, S., Kattah, M. G., Rostro, B., Colonna, M., & Sun, P. D. (2003) · Structure · doi:10.1016/j.str.2003.11.001 · Cited by 85
Begum, N. A., Ishii, K., Kurita-Taniguchi, M., Tanabe, M., Kobayashi, M., Moriwaki, Y., Matsumoto, M., Fukumori, Y., Azuma, I., Toyoshima, K., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.937-948.2004 · Cited by 80
Therapeutic approaches to innate immunity: severe sepsis and septic shock
Lolis, E., & Bucala, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1153 · Cited by 74
Cohen, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06007-x · Cited by 60
Cited by
Endotoxin tolerance: new mechanisms, molecules and clinical significance
Biswas, S. K., & Lopez-Collazo, E. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.009 · Cited by 1,318
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Kleinberger, G., Yamanishi, Y., Suárez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., Struyfs, H., Pettkus, N., Wenninger-Weinzierl, A., Mazaheri, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009093 · Cited by 798
Denning, N.-L., Aziz, M., Gurien, S. D., & Wang, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02536 · Cited by 623
The TREM receptor family and signal integration
Klesney-Tait, J., Turnbull, I. R., & Colonna, M. (2006) · Nature Immunology · doi:10.1038/ni1411 · Cited by 589
TREM and TREM-like receptors in inflammation and disease
Ford, J. W., & McVicar, D. W. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.009 · Cited by 434
Metadata
- Authors
- Gibot, S., Kolopp-Sarda, M.-N., Béné, M.-C., Bollaert, P.-E., Lozniewski, A., Mory, F., Levy, B., & Faure, G. C.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2004-11-22
- Volume
- 200
- Issue
- 11
- Pages
- 1419-1426
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2128413447
- Cited by
- 361
- References
- 35
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.